<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Prognosis Prediction</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: Aptos, 'Segoe UI', sans-serif;
            background: white;
            padding: 40px 20px;
        }
        
        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 35px 45px;
            background: white;
        }
        
        .title {
            font-size: 28px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 35px;
            text-align: center;
        }
        
        .features-grid {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 15px;
            margin-bottom: 50px;
        }
        
        .feature-card {
            background: #f8fbff;
            border: 2px solid #1E64C8;
            border-radius: 10px;
            padding: 15px 18px;
            transition: all 0.3s;
            cursor: pointer;
        }
        
        .feature-card:hover {
            transform: translateY(-3px);
            box-shadow: 0 6px 20px rgba(30, 100, 200, 0.2);
        }
        
        .feature-title {
            font-size: 17px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 8px;
        }
        
        .feature-desc {
            font-size: 16px;
            color: #333;
            line-height: 1.5;
        }

        .detailed-section {
            margin-bottom: 60px;
            padding: 30px;
            background: #f9f9f9;
            border-radius: 12px;
            border-left: 5px solid #1E64C8;
        }

        .section-title {
            font-size: 24px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 20px;
        }

        .section-content {
            font-size: 16px;
            line-height: 1.8;
            color: #333;
            margin-bottom: 25px;
        }

        .section-content h3 {
            font-size: 18px;
            font-weight: 600;
            color: #1E64C8;
            margin-top: 20px;
            margin-bottom: 10px;
        }

        .section-content ul {
            margin-left: 25px;
            margin-bottom: 15px;
        }

        .section-content li {
            margin-bottom: 8px;
        }

        .visual-example {
            background: white;
            border: 2px solid #1E64C8;
            border-radius: 10px;
            padding: 25px;
            margin-top: 20px;
        }

        .visual-title {
            font-size: 18px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 15px;
            text-align: center;
        }

        .diagram {
            background: white;
            padding: 20px;
            border-radius: 8px;
            margin: 15px 0;
        }

        .flow-diagram {
            display: flex;
            justify-content: space-around;
            align-items: center;
            flex-wrap: wrap;
            gap: 15px;
        }

        .flow-box {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 15px 20px;
            border-radius: 8px;
            min-width: 150px;
            text-align: center;
            font-weight: 600;
            box-shadow: 0 4px 6px rgba(0,0,0,0.1);
        }

        .arrow {
            font-size: 24px;
            color: #1E64C8;
            font-weight: bold;
        }

        .kaplan-meier {
            width: 100%;
            height: 300px;
            position: relative;
            border: 1px solid #ddd;
            border-radius: 8px;
            overflow: hidden;
        }

        .survival-curve {
            position: absolute;
            width: 100%;
            height: 100%;
        }

        .roc-curve {
            width: 100%;
            height: 300px;
            position: relative;
            border: 1px solid #ddd;
            border-radius: 8px;
            background: white;
        }

        .matrix-grid {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 10px;
            max-width: 500px;
            margin: 20px auto;
        }

        .matrix-cell {
            background: #e8f4f8;
            border: 2px solid #1E64C8;
            padding: 15px;
            text-align: center;
            border-radius: 8px;
            font-weight: 600;
        }

        .matrix-header {
            background: #1E64C8;
            color: white;
        }

        .chart-container {
            background: white;
            padding: 20px;
            border-radius: 8px;
            margin: 15px 0;
        }

        svg {
            width: 100%;
            height: auto;
        }

        .key-points {
            background: #fff9e6;
            border-left: 4px solid #ffc107;
            padding: 15px 20px;
            margin: 20px 0;
            border-radius: 4px;
        }

        .key-points h4 {
            color: #f57c00;
            margin-bottom: 10px;
            font-size: 16px;
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="title">Prognosis Prediction in Precision Medicine</div>
        
        <div class="features-grid">
            <div class="feature-card">
                <div class="feature-title">Multi-modal Signatures</div>
                <div class="feature-desc">Prognostic signatures from integrated data</div>
            </div>
        
            <div class="feature-card">
                <div class="feature-title">Risk Stratification</div>
                <div class="feature-desc">Identifying high-risk patients</div>
            </div>
        
            <div class="feature-card">
                <div class="feature-title">Survival Models</div>
                <div class="feature-desc">Cox regression and deep survival models</div>
            </div>
        
            <div class="feature-card">
                <div class="feature-title">Time-dependent ROC</div>
                <div class="feature-desc">Evaluating time-to-event predictions</div>
            </div>
        
            <div class="feature-card">
                <div class="feature-title">Clinical Utility</div>
                <div class="feature-desc">Decision curve analysis</div>
            </div>
        </div>

        <!-- Section 1: Multi-modal Signatures -->
        <div class="detailed-section">
            <div class="section-title">1. Multi-modal Signatures</div>
            <div class="section-content">
                <p>Multi-modal signatures integrate diverse data types to create comprehensive prognostic models that capture the complexity of disease progression. By combining genomic, transcriptomic, proteomic, imaging, and clinical data, these signatures provide a more holistic view of patient prognosis than any single data modality alone.</p>

                <h3>Key Components:</h3>
                <ul>
                    <li><strong>Genomic Data:</strong> DNA mutations, copy number variations, and structural variants that influence disease outcome</li>
                    <li><strong>Transcriptomic Data:</strong> Gene expression patterns that reflect biological state and treatment response</li>
                    <li><strong>Proteomic Data:</strong> Protein abundance and post-translational modifications</li>
                    <li><strong>Clinical Data:</strong> Patient demographics, medical history, and treatment information</li>
                    <li><strong>Imaging Data:</strong> Radiological features and pathology image characteristics</li>
                </ul>

                <h3>Integration Approaches:</h3>
                <ul>
                    <li><strong>Early Integration:</strong> Concatenate features from all modalities before model training</li>
                    <li><strong>Late Integration:</strong> Train separate models for each modality and combine predictions</li>
                    <li><strong>Intermediate Integration:</strong> Learn shared representations across modalities</li>
                </ul>

                <div class="key-points">
                    <h4>Clinical Impact:</h4>
                    Multi-modal signatures have shown superior performance in cancer prognosis, often achieving 10-20% improvement in prediction accuracy compared to single-modality approaches.
                </div>
            </div>

            <div class="visual-example">
                <div class="visual-title">Multi-modal Integration Pipeline</div>
                <div class="flow-diagram">
                    <div class="flow-box">Genomic<br>Data</div>
                    <div class="arrow">→</div>
                    <div class="flow-box">Feature<br>Extraction</div>
                    <div class="arrow">→</div>
                    <div class="flow-box">Integration<br>Layer</div>
                    <div class="arrow">→</div>
                    <div class="flow-box">Prognostic<br>Score</div>
                </div>
                <div class="flow-diagram" style="margin-top: 20px;">
                    <div class="flow-box">Clinical<br>Data</div>
                    <div class="arrow">→</div>
                    <div class="flow-box">Feature<br>Extraction</div>
                    <div class="arrow">↗</div>
                </div>
                <div class="flow-diagram" style="margin-top: 20px;">
                    <div class="flow-box">Imaging<br>Data</div>
                    <div class="arrow">→</div>
                    <div class="flow-box">Feature<br>Extraction</div>
                    <div class="arrow">↗</div>
                </div>
            </div>
        </div>

        <!-- Section 2: Risk Stratification -->
        <div class="detailed-section">
            <div class="section-title">2. Risk Stratification</div>
            <div class="section-content">
                <p>Risk stratification categorizes patients into distinct groups based on their predicted clinical outcomes, enabling personalized treatment decisions. This approach allows clinicians to identify high-risk patients who may benefit from aggressive interventions and low-risk patients who may safely avoid unnecessary treatments.</p>

                <h3>Stratification Methods:</h3>
                <ul>
                    <li><strong>Score-based Stratification:</strong> Divide patients using continuous risk scores (e.g., quartiles, tertiles)</li>
                    <li><strong>Clustering Approaches:</strong> Unsupervised grouping based on molecular or clinical profiles</li>
                    <li><strong>Tree-based Methods:</strong> Recursive partitioning to identify natural risk groups</li>
                    <li><strong>Machine Learning Classification:</strong> Supervised learning to predict risk categories</li>
                </ul>

                <h3>Common Risk Groups:</h3>
                <ul>
                    <li><strong>Low Risk:</strong> Favorable prognosis, may benefit from treatment de-escalation</li>
                    <li><strong>Intermediate Risk:</strong> Standard treatment protocols appropriate</li>
                    <li><strong>High Risk:</strong> Poor prognosis, candidates for intensive therapy or clinical trials</li>
                </ul>

                <div class="key-points">
                    <h4>Example Application:</h4>
                    In breast cancer, the Oncotype DX recurrence score stratifies patients into low, intermediate, and high-risk groups, guiding decisions about adjuvant chemotherapy. Studies show that 70% of patients classified as low-risk can safely avoid chemotherapy.
                </div>
            </div>

            <div class="visual-example">
                <div class="visual-title">Risk Stratification Example</div>
                <div class="chart-container">
                    <svg viewBox="0 0 600 350" style="max-height: 350px;">
                        <!-- Axes -->
                        <line x1="50" y1="300" x2="550" y2="300" stroke="#333" stroke-width="2"/>
                        <line x1="50" y1="300" x2="50" y2="30" stroke="#333" stroke-width="2"/>
                        
                        <!-- Y-axis label -->
                        <text x="20" y="160" transform="rotate(-90 20 160)" font-size="14" fill="#333">Survival Probability</text>
                        <text x="300" y="335" font-size="14" fill="#333" text-anchor="middle">Time (months)</text>
                        
                        <!-- Y-axis ticks -->
                        <text x="45" y="305" font-size="12" fill="#333" text-anchor="end">0</text>
                        <text x="45" y="235" font-size="12" fill="#333" text-anchor="end">0.2</text>
                        <text x="45" y="165" font-size="12" fill="#333" text-anchor="end">0.4</text>
                        <text x="45" y="95" font-size="12" fill="#333" text-anchor="end">0.6</text>
                        <text x="45" y="35" font-size="12" fill="#333" text-anchor="end">1.0</text>
                        
                        <!-- X-axis ticks -->
                        <text x="50" y="320" font-size="12" fill="#333" text-anchor="middle">0</text>
                        <text x="175" y="320" font-size="12" fill="#333" text-anchor="middle">20</text>
                        <text x="300" y="320" font-size="12" fill="#333" text-anchor="middle">40</text>
                        <text x="425" y="320" font-size="12" fill="#333" text-anchor="middle">60</text>
                        <text x="550" y="320" font-size="12" fill="#333" text-anchor="middle">80</text>
                        
                        <!-- Low Risk Curve (green) -->
                        <path d="M 50 30 L 175 35 L 300 50 L 425 70 L 550 95" 
                              stroke="#2e7d32" stroke-width="3" fill="none"/>
                        
                        <!-- Intermediate Risk Curve (orange) -->
                        <path d="M 50 30 L 175 60 L 300 110 L 425 165 L 550 210" 
                              stroke="#f57c00" stroke-width="3" fill="none"/>
                        
                        <!-- High Risk Curve (red) -->
                        <path d="M 50 30 L 175 95 L 300 165 L 425 230 L 550 270" 
                              stroke="#c62828" stroke-width="3" fill="none"/>
                        
                        <!-- Legend -->
                        <rect x="380" y="50" width="150" height="90" fill="white" stroke="#ccc" stroke-width="1" rx="5"/>
                        <line x1="390" y1="70" x2="420" y2="70" stroke="#2e7d32" stroke-width="3"/>
                        <text x="430" y="75" font-size="13" fill="#333">Low Risk</text>
                        <line x1="390" y1="95" x2="420" y2="95" stroke="#f57c00" stroke-width="3"/>
                        <text x="430" y="100" font-size="13" fill="#333">Intermediate</text>
                        <line x1="390" y1="120" x2="420" y2="120" stroke="#c62828" stroke-width="3"/>
                        <text x="430" y="125" font-size="13" fill="#333">High Risk</text>
                    </svg>
                    <p style="text-align: center; margin-top: 15px; font-size: 14px; color: #666;">
                        Kaplan-Meier survival curves showing distinct outcomes across risk groups
                    </p>
                </div>
            </div>
        </div>

        <!-- Section 3: Survival Models -->
        <div class="detailed-section">
            <div class="section-title">3. Survival Models</div>
            <div class="section-content">
                <p>Survival models analyze time-to-event data, accounting for censored observations where the event of interest has not occurred by the end of follow-up. These models are essential for prognosis prediction as they handle the temporal nature of clinical outcomes.</p>

                <h3>Cox Proportional Hazards Model:</h3>
                <ul>
                    <li><strong>Semi-parametric approach:</strong> Makes no assumptions about baseline hazard function</li>
                    <li><strong>Hazard Ratio:</strong> h(t) = h₀(t) × exp(β₁x₁ + β₂x₂ + ... + βₚxₚ)</li>
                    <li><strong>Interpretability:</strong> Coefficients represent log-hazard ratios, easily interpretable</li>
                    <li><strong>Limitations:</strong> Assumes proportional hazards, linear relationships</li>
                </ul>

                <h3>Deep Survival Models:</h3>
                <ul>
                    <li><strong>DeepSurv:</strong> Neural network extension of Cox model, captures non-linear relationships</li>
                    <li><strong>Neural Multi-Task Logistic Regression:</strong> Predicts discrete-time survival probabilities</li>
                    <li><strong>Variational Autoencoders:</strong> Learn latent representations for survival prediction</li>
                    <li><strong>Advantages:</strong> Handle complex interactions, integrate multiple data types, no proportional hazards assumption</li>
                </ul>

                <div class="key-points">
                    <h4>Model Selection Guidelines:</h4>
                    Cox regression is preferred when interpretability is crucial and sample sizes are moderate. Deep learning approaches excel with large datasets (>1000 samples) and complex, multi-modal data where non-linear relationships are expected.
                </div>
            </div>

            <div class="visual-example">
                <div class="visual-title">Survival Model Comparison</div>
                <div class="matrix-grid">
                    <div class="matrix-cell matrix-header">Model</div>
                    <div class="matrix-cell matrix-header">Strengths</div>
                    <div class="matrix-cell matrix-header">Use Cases</div>
                    
                    <div class="matrix-cell" style="background: #e3f2fd;">Cox Regression</div>
                    <div class="matrix-cell">Interpretable<br>Statistical rigor</div>
                    <div class="matrix-cell">Clinical trials<br>Small datasets</div>
                    
                    <div class="matrix-cell" style="background: #f3e5f5;">DeepSurv</div>
                    <div class="matrix-cell">Non-linear<br>Multi-modal</div>
                    <div class="matrix-cell">Large cohorts<br>Complex data</div>
                    
                    <div class="matrix-cell" style="background: #e8f5e9;">Random<br>Survival Forest</div>
                    <div class="matrix-cell">Robust<br>Variable selection</div>
                    <div class="matrix-cell">High-dimensional<br>Genomics</div>
                </div>
                
                <div style="margin-top: 30px; padding: 20px; background: white; border-radius: 8px;">
                    <h4 style="color: #1E64C8; margin-bottom: 15px;">Hazard Function Visualization</h4>
                    <svg viewBox="0 0 600 250" style="max-height: 250px;">
                        <line x1="50" y1="200" x2="550" y2="200" stroke="#333" stroke-width="2"/>
                        <line x1="50" y1="200" x2="50" y2="30" stroke="#333" stroke-width="2"/>
                        
                        <text x="300" y="235" font-size="14" fill="#333" text-anchor="middle">Time</text>
                        <text x="20" y="120" transform="rotate(-90 20 120)" font-size="14" fill="#333">Hazard Rate</text>
                        
                        <!-- Baseline hazard (dotted line) -->
                        <path d="M 50 150 Q 200 140 300 135 T 550 130" 
                              stroke="#999" stroke-width="2" fill="none" stroke-dasharray="5,5"/>
                        
                        <!-- High risk group -->
                        <path d="M 50 80 Q 200 75 300 73 T 550 70" 
                              stroke="#c62828" stroke-width="3" fill="none"/>
                        
                        <!-- Low risk group -->
                        <path d="M 50 170 Q 200 168 300 167 T 550 165" 
                              stroke="#2e7d32" stroke-width="3" fill="none"/>
                        
                        <!-- Legend -->
                        <rect x="380" y="40" width="160" height="80" fill="white" stroke="#ccc" rx="5"/>
                        <line x1="390" y1="60" x2="420" y2="60" stroke="#c62828" stroke-width="3"/>
                        <text x="430" y="65" font-size="12" fill="#333">High Risk Group</text>
                        <line x1="390" y1="85" x2="420" y2="85" stroke="#999" stroke-width="2" stroke-dasharray="5,5"/>
                        <text x="430" y="90" font-size="12" fill="#333">Baseline Hazard</text>
                        <line x1="390" y1="110" x2="420" y2="110" stroke="#2e7d32" stroke-width="3"/>
                        <text x="430" y="115" font-size="12" fill="#333">Low Risk Group</text>
                    </svg>
                </div>
            </div>
        </div>

        <!-- Section 4: Time-dependent ROC -->
        <div class="detailed-section">
            <div class="section-title">4. Time-dependent ROC</div>
            <div class="section-content">
                <p>Time-dependent Receiver Operating Characteristic (ROC) analysis evaluates the discriminative ability of survival models at specific time points. Unlike standard ROC analysis, it accounts for censoring and the time-varying nature of survival predictions.</p>

                <h3>Key Concepts:</h3>
                <ul>
                    <li><strong>Sensitivity (True Positive Rate):</strong> Proportion of patients who experienced the event by time t and were correctly classified as high-risk</li>
                    <li><strong>Specificity (True Negative Rate):</strong> Proportion of patients who remained event-free by time t and were correctly classified as low-risk</li>
                    <li><strong>AUC(t):</strong> Area under the time-dependent ROC curve at time t; ranges from 0.5 (no discrimination) to 1.0 (perfect discrimination)</li>
                    <li><strong>Time-varying Performance:</strong> Model performance may change over time, requiring evaluation at multiple clinically relevant time points</li>
                </ul>

                <h3>Evaluation Strategy:</h3>
                <ul>
                    <li><strong>Multiple Time Points:</strong> Assess performance at 1-year, 3-year, 5-year survival</li>
                    <li><strong>Integrated AUC:</strong> Summary measure across time range</li>
                    <li><strong>Censoring Adjustments:</strong> Use inverse probability weighting or other methods to handle censored data</li>
                </ul>

                <div class="key-points">
                    <h4>Performance Benchmarks:</h4>
                    In oncology, an AUC > 0.70 is considered acceptable, > 0.75 good, and > 0.80 excellent for prognostic models. Clinical deployment typically requires AUC > 0.75 with validation in independent cohorts.
                </div>
            </div>

            <div class="visual-example">
                <div class="visual-title">Time-dependent ROC Analysis</div>
                <div class="chart-container">
                    <svg viewBox="0 0 600 400" style="max-height: 400px;">
                        <!-- Main ROC plot -->
                        <line x1="50" y1="350" x2="350" y2="350" stroke="#333" stroke-width="2"/>
                        <line x1="50" y1="350" x2="50" y2="50" stroke="#333" stroke-width="2"/>
                        
                        <text x="200" y="385" font-size="14" fill="#333" text-anchor="middle">1 - Specificity (FPR)</text>
                        <text x="20" y="200" transform="rotate(-90 20 200)" font-size="14" fill="#333">Sensitivity (TPR)</text>
                        
                        <!-- Diagonal reference line -->
                        <line x1="50" y1="350" x2="350" y2="50" stroke="#999" stroke-width="1" stroke-dasharray="5,5"/>
                        
                        <!-- ROC curves for different time points -->
                        <!-- 1-year (blue) -->
                        <path d="M 50 350 L 80 250 L 120 150 L 180 100 L 250 70 L 350 50" 
                              stroke="#1976d2" stroke-width="3" fill="none"/>
                        
                        <!-- 3-year (green) -->
                        <path d="M 50 350 L 75 270 L 110 180 L 160 120 L 220 85 L 350 50" 
                              stroke="#388e3c" stroke-width="3" fill="none"/>
                        
                        <!-- 5-year (orange) -->
                        <path d="M 50 350 L 70 290 L 100 210 L 140 150 L 190 110 L 350 50" 
                              stroke="#f57c00" stroke-width="3" fill="none"/>
                        
                        <!-- AUC values display -->
                        <rect x="370" y="80" width="210" height="140" fill="white" stroke="#1E64C8" stroke-width="2" rx="8"/>
                        <text x="475" y="110" font-size="16" fill="#1E64C8" text-anchor="middle" font-weight="bold">AUC Values</text>
                        
                        <line x1="385" y1="135" x2="415" y2="135" stroke="#1976d2" stroke-width="3"/>
                        <text x="425" y="140" font-size="14" fill="#333">1-year: 0.85</text>
                        
                        <line x1="385" y1="165" x2="415" y2="165" stroke="#388e3c" stroke-width="3"/>
                        <text x="425" y="170" font-size="14" fill="#333">3-year: 0.81</text>
                        
                        <line x1="385" y1="195" x2="415" y2="195" stroke="#f57c00" stroke-width="3"/>
                        <text x="425" y="200" font-size="14" fill="#333">5-year: 0.78</text>
                        
                        <!-- Axis labels -->
                        <text x="45" y="355" font-size="11" fill="#333" text-anchor="end">0.0</text>
                        <text x="45" y="275" font-size="11" fill="#333" text-anchor="end">0.25</text>
                        <text x="45" y="200" font-size="11" fill="#333" text-anchor="end">0.50</text>
                        <text x="45" y="125" font-size="11" fill="#333" text-anchor="end">0.75</text>
                        <text x="45" y="55" font-size="11" fill="#333" text-anchor="end">1.0</text>
                        
                        <text x="50" y="370" font-size="11" fill="#333" text-anchor="middle">0.0</text>
                        <text x="125" y="370" font-size="11" fill="#333" text-anchor="middle">0.25</text>
                        <text x="200" y="370" font-size="11" fill="#333" text-anchor="middle">0.50</text>
                        <text x="275" y="370" font-size="11" fill="#333" text-anchor="middle">0.75</text>
                        <text x="350" y="370" font-size="11" fill="#333" text-anchor="middle">1.0</text>
                    </svg>
                </div>
                
                <div style="margin-top: 25px; padding: 15px; background: #e3f2fd; border-radius: 8px;">
                    <p style="font-size: 14px; color: #333; line-height: 1.6;">
                        <strong>Interpretation:</strong> This example shows decreasing discriminative ability over time, 
                        which is common in prognostic models. The model performs best for short-term predictions (1-year AUC = 0.85) 
                        and slightly worse for long-term predictions (5-year AUC = 0.78), though all remain in the "good" range.
                    </p>
                </div>
            </div>
        </div>

        <!-- Section 5: Clinical Utility -->
        <div class="detailed-section">
            <div class="section-title">5. Clinical Utility</div>
            <div class="section-content">
                <p>Clinical utility assessment determines whether a prognostic model provides actionable information that improves patient outcomes or clinical decision-making. Decision curve analysis (DCA) is the gold standard for evaluating clinical utility by comparing the net benefit of using a model versus default strategies.</p>

                <h3>Decision Curve Analysis (DCA):</h3>
                <ul>
                    <li><strong>Net Benefit:</strong> Weighs true positives against false positives, accounting for the relative harm of each</li>
                    <li><strong>Threshold Probability:</strong> The probability at which a patient/clinician would opt for treatment</li>
                    <li><strong>Comparison Strategies:</strong> Model vs. "treat all" vs. "treat none"</li>
                    <li><strong>Clinical Interpretation:</strong> Shows the range of threshold probabilities where the model adds value</li>
                </ul>

                <h3>Components of Clinical Utility:</h3>
                <ul>
                    <li><strong>Actionability:</strong> Does the prediction lead to different treatment decisions?</li>
                    <li><strong>Impact on Outcomes:</strong> Does using the model improve patient survival, quality of life, or reduce costs?</li>
                    <li><strong>Implementation Feasibility:</strong> Can the model be integrated into clinical workflow?</li>
                    <li><strong>Cost-effectiveness:</strong> Does the benefit justify the cost of implementation?</li>
                </ul>

                <div class="key-points">
                    <h4>Real-World Example:</h4>
                    The 21-gene recurrence score in breast cancer demonstrates high clinical utility. Randomized trials showed that using the score to guide treatment decisions resulted in chemotherapy de-escalation in 70% of intermediate-risk patients without compromising survival, while reducing treatment toxicity and healthcare costs by $2 billion annually in the US.
                </div>
            </div>

            <div class="visual-example">
                <div class="visual-title">Decision Curve Analysis</div>
                <div class="chart-container">
                    <svg viewBox="0 0 600 400" style="max-height: 400px;">
                        <!-- Axes -->
                        <line x1="50" y1="350" x2="550" y2="350" stroke="#333" stroke-width="2"/>
                        <line x1="50" y1="350" x2="50" y2="50" stroke="#333" stroke-width="2"/>
                        
                        <text x="300" y="385" font-size="14" fill="#333" text-anchor="middle">Threshold Probability</text>
                        <text x="20" y="200" transform="rotate(-90 20 200)" font-size="14" fill="#333">Net Benefit</text>
                        
                        <!-- Treat None (baseline at y=350) -->
                        <line x1="50" y1="350" x2="550" y2="350" stroke="#999" stroke-width="2"/>
                        
                        <!-- Treat All (declining line) -->
                        <path d="M 50 100 L 150 180 L 250 250 L 350 310 L 450 340 L 550 350" 
                              stroke="#e53935" stroke-width="2" stroke-dasharray="5,5"/>
                        
                        <!-- Prognostic Model (superior curve) -->
                        <path d="M 50 100 L 150 120 L 250 150 L 350 200 L 450 280 L 550 345" 
                              stroke="#1976d2" stroke-width="3"/>
                        
                        <!-- Clinical Model -->
                        <path d="M 50 100 L 150 140 L 250 180 L 350 230 L 450 300 L 550 348" 
                              stroke="#43a047" stroke-width="3"/>
                        
                        <!-- Shaded area showing net benefit -->
                        <path d="M 150 120 L 250 150 L 350 200 L 450 280 L 450 300 L 350 230 L 250 180 L 150 140 Z" 
                              fill="#1976d2" opacity="0.2"/>
                        
                        <!-- Legend -->
                        <rect x="370" y="70" width="210" height="130" fill="white" stroke="#1E64C8" stroke-width="2" rx="8"/>
                        <text x="475" y="95" font-size="15" fill="#1E64C8" text-anchor="middle" font-weight="bold">Strategies</text>
                        
                        <line x1="385" y1="115" x2="415" y2="115" stroke="#1976d2" stroke-width="3"/>
                        <text x="425" y="120" font-size="13" fill="#333">Prognostic Model</text>
                        
                        <line x1="385" y1="140" x2="415" y2="140" stroke="#43a047" stroke-width="3"/>
                        <text x="425" y="145" font-size="13" fill="#333">Clinical Features</text>
                        
                        <line x1="385" y1="165" x2="415" y2="165" stroke="#e53935" stroke-width="2" stroke-dasharray="5,5"/>
                        <text x="425" y="170" font-size="13" fill="#333">Treat All</text>
                        
                        <line x1="385" y1="190" x2="415" y2="190" stroke="#999" stroke-width="2"/>
                        <text x="425" y="195" font-size="13" fill="#333">Treat None</text>
                        
                        <!-- Axis values -->
                        <text x="50" y="370" font-size="11" fill="#333" text-anchor="middle">0</text>
                        <text x="150" y="370" font-size="11" fill="#333" text-anchor="middle">0.2</text>
                        <text x="250" y="370" font-size="11" fill="#333" text-anchor="middle">0.4</text>
                        <text x="350" y="370" font-size="11" fill="#333" text-anchor="middle">0.6</text>
                        <text x="450" y="370" font-size="11" fill="#333" text-anchor="middle">0.8</text>
                        <text x="550" y="370" font-size="11" fill="#333" text-anchor="middle">1.0</text>
                        
                        <text x="45" y="355" font-size="11" fill="#333" text-anchor="end">0</text>
                        <text x="45" y="275" font-size="11" fill="#333" text-anchor="end">0.1</text>
                        <text x="45" y="195" font-size="11" fill="#333" text-anchor="end">0.2</text>
                        <text x="45" y="115" font-size="11" fill="#333" text-anchor="end">0.3</text>
                        
                        <!-- Annotation -->
                        <text x="200" y="110" font-size="12" fill="#1976d2" font-weight="bold">← Optimal Range →</text>
                        <line x1="150" y1="115" x2="150" y2="340" stroke="#1976d2" stroke-width="1" stroke-dasharray="3,3"/>
                        <line x1="350" y1="115" x2="350" y2="340" stroke="#1976d2" stroke-width="1" stroke-dasharray="3,3"/>
                    </svg>
                </div>
                
                <div style="margin-top: 25px;">
                    <h4 style="color: #1E64C8; margin-bottom: 15px;">Implementation Framework</h4>
                    <div class="flow-diagram">
                        <div class="flow-box" style="background: linear-gradient(135deg, #42a5f5 0%, #478ed1 100%);">
                            Validate<br>Model
                        </div>
                        <div class="arrow">→</div>
                        <div class="flow-box" style="background: linear-gradient(135deg, #66bb6a 0%, #4caf50 100%);">
                            Assess<br>Utility (DCA)
                        </div>
                        <div class="arrow">→</div>
                        <div class="flow-box" style="background: linear-gradient(135deg, #ffa726 0%, #fb8c00 100%);">
                            Clinical<br>Trial
                        </div>
                        <div class="arrow">→</div>
                        <div class="flow-box" style="background: linear-gradient(135deg, #ab47bc 0%, #8e24aa 100%);">
                            Clinical<br>Deployment
                        </div>
                    </div>
                </div>
                
                <div style="margin-top: 25px; padding: 15px; background: #fff9e6; border-left: 4px solid #ffc107; border-radius: 4px;">
                    <p style="font-size: 14px; color: #333; line-height: 1.6;">
                        <strong>Key Insight:</strong> The prognostic model (blue curve) shows superior net benefit compared to 
                        treating all patients or using clinical features alone across threshold probabilities of 0.1 to 0.6. 
                        This indicates the model is clinically useful for decision-making within this range, where most clinical 
                        decisions occur.
                    </p>
                </div>
            </div>
        </div>

        <!-- Summary Section -->
        <div style="background: linear-gradient(135deg, #667eea 0%, #764ba2 100%); color: white; padding: 30px; border-radius: 12px; margin-top: 40px;">
            <h2 style="font-size: 24px; margin-bottom: 20px; text-align: center;">Integration in Clinical Practice</h2>
            <p style="font-size: 16px; line-height: 1.8; text-align: center; max-width: 900px; margin: 0 auto;">
                Successful prognostic models combine multi-modal signatures, robust risk stratification, 
                validated survival models, rigorous time-dependent evaluation, and demonstrated clinical utility. 
                The ultimate goal is to provide actionable predictions that improve patient outcomes while 
                being feasible to implement in real-world clinical settings.
            </p>
        </div>
    </div>
</body>
</html>